Originally published
A critical look at NAD therapy claims
English editorial edition · GAAH Science

A critical look at “NAD therapy” claims
The source named in this archive, “NAD therapy,” discusses the promotion of intravenous wellness treatments and NAD-related products. It should not be read as a clinical endorsement of NMN or as a recommendation to use an infusion instead of ordinary medical care.
The original text uses a critical, sometimes ironic tone when discussing the appeal of treatments marketed as natural or rejuvenating. Reading that tone as a positive medical recommendation would reverse its meaning.
Popularity does not establish effectiveness
The archive describes celebrity attention, television promotion and the broader marketing of vitamin infusions. Such attention may explain why a treatment becomes fashionable, but it is not evidence that the intervention is necessary or effective.
The route of administration matters. A claim about an intravenous compound cannot automatically be applied to an oral precursor such as NMN.
A long list of claims requires a long list of evidence
The original discussion mentions products promoted for fatigue, cognitive conditions, mood, jet lag, athletic performance, addiction-related care and other concerns. Listing these claims does not mean the source demonstrated benefit for them.
Each claim requires evidence for the actual compound, route, population, comparator and outcome. A molecule's role in normal metabolism is not sufficient to establish treatment effectiveness.
NAD+, NADH and NMN are not the same intervention
NADH is the reduced form of NAD+. NMN is a precursor used in NAD+ biosynthesis. These distinctions are essential when evaluating a study or a marketing statement.
Different formulations and administration routes can have different metabolic and practical consequences. They should not be grouped together under a single promise of rejuvenation.
Conclusion
This entry is best understood as a discussion of the gap between wellness marketing and clinical evidence. It does not establish NAD infusions or NMN supplements as treatments for the conditions listed, and it does not test a GAAH product.
Source named in the archive: NAD therapy. The original entry did not supply a complete bibliographic reference.